Internal Medicine, Hematology & Oncology · New Orleans, LA
NPI
1003103532
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Hwy
New Orleans, LA, 70121
Phone (504) 842-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,133 services
Medicare patients, 2024
184
Average age 71
Drug cost, 2024
$1.2M
1,039 prescriptions
Company payments, 2025
$79K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lingling Du was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 416 times for 129 patients. In total Lingling Du billed 1,133 services in 14 codes, and Medicare paid $67K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 416 | 129 | $12.24 | $5,093 |
| 99215 Office E&M - Established | Facility | 311 | 79 | $105.81 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 56 | $12.36 | $1,446 |
| 99214 Office E&M - Established | Facility | 97 | 62 | $66.05 | $6,407 |
| 99215 Office E&M - Established | Office | 80 | 41 | $130.03 | $10K |
| 99214 Office E&M - Established | Office | 40 | 28 | $76.04 | $3,042 |
| 99205 Office E&M - New | Facility | 37 | 37 | $129.85 | $4,804 |
By year: 2022 $45K for 451 services; 2023 $54K for 558 services; 2024 $67K for 1,133 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lingling Du prescribed most often to Medicare patients was Ondansetron Odt (Ondansetron), with 75 prescriptions and refills. In total Lingling Du wrote 1,039 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | 75 | 75 | 50 | $1,245 |
| Oxycodone Hcl Generic | 51 | 51 | 28 | $891 |
| Eliquis Apixaban | 45 | 69 | 16 | $40K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 45 | 45 | 39 | $751 |
| Duloxetine Hcl Generic | 44 | 54 | Under 11 | $355 |
| Letrozole Generic | 43 | 117 | 11 | $1,174 |
| Olanzapine Generic | 40 | 50 | 25 | $355 |
| Promethazine Hcl Generic | 36 | 36 | 25 | $468 |
| Cyproheptadine Hcl Generic | 36 | 36 | 19 | $693 |
| Gabapentin Generic | 30 | 38 | 12 | $281 |
| Creon Lipase/Protease/Amylase | 30 | 35 | Under 11 | $43K |
| Enoxaparin Sodium Generic | 27 | 27 | Under 11 | $11K |
| Prochlorperazine Maleate Generic | 27 | 27 | 20 | $309 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 26 | 27 | 12 | $933 |
| Xermelo Telotristat Etiprate | 22 | 22 | Under 11 | $191K |
Brand drugs: 176 claims; generic drugs: 863 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lingling Du $79K ($79K in general payments such as food, travel and fees) from 18 companies. The largest payer was Exelixis Inc. with $36K.
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. EXEL | 69 | $36K |
| Boston Scientific Corporation BSX | 41 | $34K |
| Sirtex Medical Inc | 7 | $4,548 |
| BeOne Medicines USA, Inc. ONC | 4 | $2,008 |
| Incyte Corporation INCY | 1 | $1,100 |
| Eisai Inc. 4523.T | 1 | $790 |
| Intera Oncology, Inc | 1 | $202 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $181 |
| TerSera Therapeutics LLC | 3 | $83.3 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $25.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.